157 related articles for article (PubMed ID: 23238211)
1. Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis.
Allott EH; Morine MJ; Lysaght J; McGarrigle SA; Donohoe CL; Reynolds JV; Roche HM; Pidgeon GP
Clin Transl Gastroenterol; 2012 Apr; 3(4):e12. PubMed ID: 23238211
[TBL] [Abstract][Full Text] [Related]
2. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
3. Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma.
Lynam-Lennon N; Connaughton R; Carr E; Mongan AM; O'Farrell NJ; Porter RK; Brennan L; Pidgeon GP; Lysaght J; Reynolds JV; O'Sullivan J
BMC Cancer; 2014 Dec; 14():907. PubMed ID: 25471892
[TBL] [Abstract][Full Text] [Related]
4. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation.
Allott EH; Lysaght J; Cathcart MC; Donohoe CL; Cummins R; McGarrigle SA; Kay E; Reynolds JV; Pidgeon GP
Mol Carcinog; 2013 Feb; 52(2):144-54. PubMed ID: 22121096
[TBL] [Abstract][Full Text] [Related]
5. Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.
Wang L; Jin JQ; Zhou Y; Tian Z; Jablons DM; He B
Oncotarget; 2018 Jan; 9(1):853-865. PubMed ID: 29416661
[TBL] [Abstract][Full Text] [Related]
6. Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion.
Trevellin E; Scarpa M; Carraro A; Lunardi F; Kotsafti A; Porzionato A; Saadeh L; Cagol M; Alfieri R; Tedeschi U; Calabrese F; Castoro C; Vettor R
Oncotarget; 2015 May; 6(13):11203-15. PubMed ID: 25857300
[TBL] [Abstract][Full Text] [Related]
7. Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.
Blum AE; Venkitachalam S; Ravillah D; Chelluboyina AK; Kieber-Emmons AM; Ravi L; Kresak A; Chandar AK; Markowitz SD; Canto MI; Wang JS; Shaheen NJ; Guo Y; Shyr Y; Willis JE; Chak A; Varadan V; Guda K
Gastroenterology; 2019 May; 156(6):1761-1774. PubMed ID: 30768984
[TBL] [Abstract][Full Text] [Related]
8. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
[TBL] [Abstract][Full Text] [Related]
9. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.
Samad F; Yamamoto K; Pandey M; Loskutoff DJ
Mol Med; 1997 Jan; 3(1):37-48. PubMed ID: 9132278
[TBL] [Abstract][Full Text] [Related]
11. Co-overexpression of AXL and c-ABL predicts a poor prognosis in esophageal adenocarcinoma and promotes cancer cell survival.
Hong J; Abid F; Phillips S; Salaria SN; Revetta FL; Peng D; Washington MK; El-Rifai W; Belkhiri A
J Cancer; 2020; 11(20):5867-5879. PubMed ID: 32922529
[No Abstract] [Full Text] [Related]
12. SNAI2 is induced by transforming growth factor-β1, but is not essential for epithelial-mesenchymal transition in human keratinocyte HaCaT cells.
Miyake Y; Nagaoka Y; Okamura K; Takeishi Y; Tamaoki S; Hatta M
Exp Ther Med; 2021 Oct; 22(4):1124. PubMed ID: 34466140
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
14. EMX2 is epigenetically silenced and suppresses epithelial‑mesenchymal transition in human esophageal adenocarcinoma.
Wang L; Jin J; Zhou Y; Tian Z; He B; Huang Y; Ding F
Oncol Rep; 2019 Nov; 42(5):2169-2178. PubMed ID: 31432154
[TBL] [Abstract][Full Text] [Related]
15. Visceral adipose tissue: the link with esophageal adenocarcinoma.
Massl R; van Blankenstein M; Jeurnink S; Hermans JJ; de Haan MC; Stoker J; Koek M; Niessen WJ; Steyerberg EW; Looman CW; Kuipers EJ
Scand J Gastroenterol; 2014 Apr; 49(4):449-57. PubMed ID: 24467299
[TBL] [Abstract][Full Text] [Related]
16. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma.
Ebbing EA; van der Zalm AP; Steins A; Creemers A; Hermsen S; Rentenaar R; Klein M; Waasdorp C; Hooijer GKJ; Meijer SL; Krishnadath KK; Punt CJA; van Berge Henegouwen MI; Gisbertz SS; van Delden OM; Hulshof MCCM; Medema JP; van Laarhoven HWM; Bijlsma MF
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2237-2242. PubMed ID: 30670657
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.
Samad F; Loskutoff DJ
Mol Med; 1996 Sep; 2(5):568-82. PubMed ID: 8898373
[TBL] [Abstract][Full Text] [Related]
18. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
Kim SM; Park YY; Park ES; Cho JY; Izzo JG; Zhang D; Kim SB; Lee JH; Bhutani MS; Swisher SG; Wu X; Coombes KR; Maru D; Wang KK; Buttar NS; Ajani JA; Lee JS
PLoS One; 2010 Nov; 5(11):e15074. PubMed ID: 21152079
[TBL] [Abstract][Full Text] [Related]
19. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
20. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
